schizandrin b has been researched along with bosentan anhydrous in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (bosentan anhydrous) | Trials (bosentan anhydrous) | Recent Studies (post-2010) (bosentan anhydrous) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 1,836 | 215 | 630 |
| Protein | Taxonomy | schizandrin b (IC50) | bosentan anhydrous (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | 0.095 | |
| Endothelin receptor type B | Homo sapiens (human) | 0.3044 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.2317 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 0.0047 | |
| Endothelin-1 receptor | Sus scrofa (pig) | 0.0075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, Y; Guo, F; Li, S; Wang, S; Wei, J; Wu, H; Yang, H; Yu, Y; Zhang, M | 1 |
1 other study(ies) available for schizandrin b and bosentan anhydrous
| Article | Year |
|---|---|
Identification of active components in Yixinshu Capsule with protective effects against myocardial dysfunction on human induced pluripotent stem cell-derived cardiomyocytes by an integrative approach.
Topics: Actinin; Animals; Bosentan; Cardiotonic Agents; Cell Differentiation; Cell Line; Cyclooctanes; Drugs, Chinese Herbal; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation; Humans; Induced Pluripotent Stem Cells; Intestinal Mucosa; Intestines; Lignans; Male; Medicine, Chinese Traditional; Metabolic Networks and Pathways; Metabolome; Myocytes, Cardiac; Natriuretic Peptide, Brain; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Sulfonamides; Troponin T | 2017 |